BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23937086)

  • 1. Glucagon-like peptide-1 protects human islets against cytokine-mediated β-cell dysfunction and death: a proteomic study of the pathways involved.
    Rondas D; Bugliani M; D'Hertog W; Lage K; Masini M; Waelkens E; Marchetti P; Mathieu C; Overbergh L
    J Proteome Res; 2013 Sep; 12(9):4193-206. PubMed ID: 23937086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: a proteomic study.
    Ciregia F; Giusti L; Ronci M; Bugliani M; Piga I; Pieroni L; Rossi C; Marchetti P; Urbani A; Lucacchini A
    Mol Biosyst; 2015 Jun; 11(6):1696-707. PubMed ID: 25912719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk.
    He W; Rebello OD; Henne A; Nikolka F; Klein T; Maedler K
    Front Endocrinol (Lausanne); 2021; 12():697120. PubMed ID: 34290670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
    Edén D; Siegbahn A; Mokhtari D
    Diabetologia; 2015 Nov; 58(11):2563-72. PubMed ID: 26271343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effects of glucagon-like peptide-1 on interferon-gamma-induced nitric oxide production in insulin-producing cells is mediated by inhibition of tumor necrosis factor-alpha production.
    Hahm E; Lee YS; Jun HS
    J Endocrinol Invest; 2008 Apr; 31(4):334-40. PubMed ID: 18475052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.
    Shah P; Ardestani A; Dharmadhikari G; Laue S; Schumann DM; Kerr-Conte J; Pattou F; Klein T; Maedler K
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1163-72. PubMed ID: 23633194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
    Farilla L; Hui H; Bertolotto C; Kang E; Bulotta A; Di Mario U; Perfetti R
    Endocrinology; 2002 Nov; 143(11):4397-408. PubMed ID: 12399437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy.
    Linnemann AK; Blumer J; Marasco MR; Battiola TJ; Umhoefer HM; Han JY; Lamming DW; Davis DB
    FASEB J; 2017 Sep; 31(9):4140-4152. PubMed ID: 28592636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1.
    Blandino-Rosano M; Perez-Arana G; Mellado-Gil JM; Segundo C; Aguilar-Diosdado M
    J Mol Endocrinol; 2008 Jul; 41(1):35-44. PubMed ID: 18487229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
    Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
    Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
    Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets.
    Tudurí E; López M; Diéguez C; Nadal A; Nogueiras R
    Trends Endocrinol Metab; 2016 May; 27(5):304-318. PubMed ID: 27062006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
    Uhles S; Wang H; Bénardeau A; Prummer M; Brecheisen M; Sewing S; Tobalina L; Bosco D; Wollheim CB; Migliorini C; Sebokova E
    Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
    Linnemann AK; Neuman JC; Battiola TJ; Wisinski JA; Kimple ME; Davis DB
    Mol Endocrinol; 2015 Jul; 29(7):978-87. PubMed ID: 25984632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?
    Hansen AM; Bödvarsdottir TB; Nordestgaard DN; Heller RS; Gotfredsen CF; Maedler K; Fels JJ; Holst JJ; Karlsen AE
    Diabetologia; 2011 Jun; 54(6):1379-87. PubMed ID: 21347622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
    Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
    Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death.
    Wei D; Li J; Shen M; Jia W; Chen N; Chen T; Su D; Tian H; Zheng S; Dai Y; Zhao A
    Diabetes; 2010 Feb; 59(2):471-8. PubMed ID: 19933995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival.
    Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
    Peptides; 2017 Sep; 95():68-75. PubMed ID: 28746825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.